RLAYRelay Therapeutics, Inc.

$19.45

Is it safe?

Can RLAY take a bad year?

The deepest fall in RLAY's price history on file is −97%; it is −6.4% below its high today.

37.91

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Annualised volatility
81%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−97%

Worst drawdown on file · −6.4% today

Details
Cash and short-term investments
$121M
EBITDA, trailing twelve months
−$308M
Operating profit, trailing twelve months
−$310M
Annualised volatilitytwo years of daily moves
81%
Worst drawdown on file
−97%
Below its 52-week high
−6.4%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.